Cardiomyopathy induced by artificial cardiac pacing: myth or reality sustained by evidence?
Autor(a) principal: | |
---|---|
Data de Publicação: | 2014 |
Outros Autores: | , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Brazilian Journal of Cardiovascular Surgery (Online) |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382014000300402 |
Resumo: | Implantable cardiac pacing systems are a safe and effective treatment for symptomatic irreversible bradycardia. Under the proper indications, cardiac pacing might bring significant clinical benefit. Evidences from literature state that the action of the artificial pacing system, mainly when the ventricular lead is located at the apex of the right ventricle, produces negative effects to cardiac structure (remodeling, dilatation) and function (dissinchrony). Patients with previously compromised left ventricular function would benefit the least with conventional right ventricle apical pacing, and are exposed to the risk of developing higher incidence of morbidity and mortality for heart failure. However, after almost 6 decades of cardiac pacing, just a reduced portion of patients in general would develop these alterations. In this context, there are not completely clear some issues related to cardiac pacing and the development of this cardiomyopathy. Causality relationships among QRS widening with a left bundle branch block morphology, contractility alterations within the left ventricle, and certain substrates or clinical (previous systolic dysfunction, structural heart disease, time from implant) or electrical conditions (QRS duration, percentage of ventricular stimulation) are still subjecte of debate. This review analyses contemporary data regarding this new entity, and discusses alternatives of how to use cardiac pacing in this context, emphasizing cardiac resynchronization therapy. |
id |
SBCCV-1_cdd55e22ca3f7e54ae8164f8d1f33b32 |
---|---|
oai_identifier_str |
oai:scielo:S0102-76382014000300402 |
network_acronym_str |
SBCCV-1 |
network_name_str |
Brazilian Journal of Cardiovascular Surgery (Online) |
repository_id_str |
|
spelling |
Cardiomyopathy induced by artificial cardiac pacing: myth or reality sustained by evidence?Pacemaker, ArtificialCardiomyopathy, DilatedVentricular DysfunctionImplantable cardiac pacing systems are a safe and effective treatment for symptomatic irreversible bradycardia. Under the proper indications, cardiac pacing might bring significant clinical benefit. Evidences from literature state that the action of the artificial pacing system, mainly when the ventricular lead is located at the apex of the right ventricle, produces negative effects to cardiac structure (remodeling, dilatation) and function (dissinchrony). Patients with previously compromised left ventricular function would benefit the least with conventional right ventricle apical pacing, and are exposed to the risk of developing higher incidence of morbidity and mortality for heart failure. However, after almost 6 decades of cardiac pacing, just a reduced portion of patients in general would develop these alterations. In this context, there are not completely clear some issues related to cardiac pacing and the development of this cardiomyopathy. Causality relationships among QRS widening with a left bundle branch block morphology, contractility alterations within the left ventricle, and certain substrates or clinical (previous systolic dysfunction, structural heart disease, time from implant) or electrical conditions (QRS duration, percentage of ventricular stimulation) are still subjecte of debate. This review analyses contemporary data regarding this new entity, and discusses alternatives of how to use cardiac pacing in this context, emphasizing cardiac resynchronization therapy.Sociedade Brasileira de Cirurgia Cardiovascular2014-09-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382014000300402Brazilian Journal of Cardiovascular Surgery v.29 n.3 2014reponame:Brazilian Journal of Cardiovascular Surgery (Online)instname:Sociedade Brasileira de Cirurgia Cardiovascular (SBCCV)instacron:SBCCV10.5935/1678-9741.20140104info:eu-repo/semantics/openAccessFerrari,Andrés Di LeoniBorges,Anibal PiresAlbuquerque,Luciano CabralSussenbach,Carolina PelzerRosa,Priscila Raupp daPiantá,Ricardo MedeirosWiehe,MarioGoldani,Marco Antônioeng2014-10-29T00:00:00Zoai:scielo:S0102-76382014000300402Revistahttp://www.rbccv.org.br/https://old.scielo.br/oai/scielo-oai.php||rosangela.monteiro@incor.usp.br|| domingo@braile.com.br|| brandau@braile.com.br1678-97410102-7638opendoar:2014-10-29T00:00Brazilian Journal of Cardiovascular Surgery (Online) - Sociedade Brasileira de Cirurgia Cardiovascular (SBCCV)false |
dc.title.none.fl_str_mv |
Cardiomyopathy induced by artificial cardiac pacing: myth or reality sustained by evidence? |
title |
Cardiomyopathy induced by artificial cardiac pacing: myth or reality sustained by evidence? |
spellingShingle |
Cardiomyopathy induced by artificial cardiac pacing: myth or reality sustained by evidence? Ferrari,Andrés Di Leoni Pacemaker, Artificial Cardiomyopathy, Dilated Ventricular Dysfunction |
title_short |
Cardiomyopathy induced by artificial cardiac pacing: myth or reality sustained by evidence? |
title_full |
Cardiomyopathy induced by artificial cardiac pacing: myth or reality sustained by evidence? |
title_fullStr |
Cardiomyopathy induced by artificial cardiac pacing: myth or reality sustained by evidence? |
title_full_unstemmed |
Cardiomyopathy induced by artificial cardiac pacing: myth or reality sustained by evidence? |
title_sort |
Cardiomyopathy induced by artificial cardiac pacing: myth or reality sustained by evidence? |
author |
Ferrari,Andrés Di Leoni |
author_facet |
Ferrari,Andrés Di Leoni Borges,Anibal Pires Albuquerque,Luciano Cabral Sussenbach,Carolina Pelzer Rosa,Priscila Raupp da Piantá,Ricardo Medeiros Wiehe,Mario Goldani,Marco Antônio |
author_role |
author |
author2 |
Borges,Anibal Pires Albuquerque,Luciano Cabral Sussenbach,Carolina Pelzer Rosa,Priscila Raupp da Piantá,Ricardo Medeiros Wiehe,Mario Goldani,Marco Antônio |
author2_role |
author author author author author author author |
dc.contributor.author.fl_str_mv |
Ferrari,Andrés Di Leoni Borges,Anibal Pires Albuquerque,Luciano Cabral Sussenbach,Carolina Pelzer Rosa,Priscila Raupp da Piantá,Ricardo Medeiros Wiehe,Mario Goldani,Marco Antônio |
dc.subject.por.fl_str_mv |
Pacemaker, Artificial Cardiomyopathy, Dilated Ventricular Dysfunction |
topic |
Pacemaker, Artificial Cardiomyopathy, Dilated Ventricular Dysfunction |
description |
Implantable cardiac pacing systems are a safe and effective treatment for symptomatic irreversible bradycardia. Under the proper indications, cardiac pacing might bring significant clinical benefit. Evidences from literature state that the action of the artificial pacing system, mainly when the ventricular lead is located at the apex of the right ventricle, produces negative effects to cardiac structure (remodeling, dilatation) and function (dissinchrony). Patients with previously compromised left ventricular function would benefit the least with conventional right ventricle apical pacing, and are exposed to the risk of developing higher incidence of morbidity and mortality for heart failure. However, after almost 6 decades of cardiac pacing, just a reduced portion of patients in general would develop these alterations. In this context, there are not completely clear some issues related to cardiac pacing and the development of this cardiomyopathy. Causality relationships among QRS widening with a left bundle branch block morphology, contractility alterations within the left ventricle, and certain substrates or clinical (previous systolic dysfunction, structural heart disease, time from implant) or electrical conditions (QRS duration, percentage of ventricular stimulation) are still subjecte of debate. This review analyses contemporary data regarding this new entity, and discusses alternatives of how to use cardiac pacing in this context, emphasizing cardiac resynchronization therapy. |
publishDate |
2014 |
dc.date.none.fl_str_mv |
2014-09-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382014000300402 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382014000300402 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.5935/1678-9741.20140104 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Sociedade Brasileira de Cirurgia Cardiovascular |
publisher.none.fl_str_mv |
Sociedade Brasileira de Cirurgia Cardiovascular |
dc.source.none.fl_str_mv |
Brazilian Journal of Cardiovascular Surgery v.29 n.3 2014 reponame:Brazilian Journal of Cardiovascular Surgery (Online) instname:Sociedade Brasileira de Cirurgia Cardiovascular (SBCCV) instacron:SBCCV |
instname_str |
Sociedade Brasileira de Cirurgia Cardiovascular (SBCCV) |
instacron_str |
SBCCV |
institution |
SBCCV |
reponame_str |
Brazilian Journal of Cardiovascular Surgery (Online) |
collection |
Brazilian Journal of Cardiovascular Surgery (Online) |
repository.name.fl_str_mv |
Brazilian Journal of Cardiovascular Surgery (Online) - Sociedade Brasileira de Cirurgia Cardiovascular (SBCCV) |
repository.mail.fl_str_mv |
||rosangela.monteiro@incor.usp.br|| domingo@braile.com.br|| brandau@braile.com.br |
_version_ |
1752126598556942336 |